Testing effectiveness (Phase 2)Not Yet RecruitingNCT06789302
What this trial is testing
A Double-Blind, Randomized, Placebo-Controlled Phase IIa Clinical Trial to Evaluate the Safety and Efficacy of DT2-SCT in Subjects With Type 2 Diabetes Mellitus
Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Global Institute of Stem Cell Therapy and Research 120